HUP9904011A2 - Novel salts of dipeptid derivatives and use of them for producing pharmaceutical compositions - Google Patents
Novel salts of dipeptid derivatives and use of them for producing pharmaceutical compositionsInfo
- Publication number
- HUP9904011A2 HUP9904011A2 HU9904011A HUP9904011A HUP9904011A2 HU P9904011 A2 HUP9904011 A2 HU P9904011A2 HU 9904011 A HU9904011 A HU 9904011A HU P9904011 A HUP9904011 A HU P9904011A HU P9904011 A2 HUP9904011 A2 HU P9904011A2
- Authority
- HU
- Hungary
- Prior art keywords
- dipeptid
- derivatives
- pharmaceutical compositions
- salts
- producing pharmaceutical
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 108010061435 Enalapril Proteins 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical group [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- -1 alkaline earth metal salts Chemical class 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 abstract 1
- 229960000873 enalapril Drugs 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány tárgya új (1S)-N-(1-etoxikarbonil-3-fenilpropil)-L-alanil-L-prolin (nemzetközi szabad nevén: enalapril) (I) általános képletűalkáli- és alkáli földfém-sók - ahol a képletben X jelentése kálium-,kálcium- vagy magnézium-atom - valamint ezen sók szolvátjai. Atalálmány a fenti új sók keringési betegségek gyógyítására szolgálógyógyszerkészítményekben való alkalmazására is vonatkozik. ÓThe subject of the invention is new (1S)-N-(1-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline (international free name: enalapril) alkali and alkaline earth metal salts of general formula (I) - where X in the formula means a potassium, calcium or magnesium atom - as well as solvates of these salts. The invention also applies to the use of the above new salts in medicinal preparations for the treatment of circulatory diseases. HE
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9904011A HU226950B1 (en) | 1999-11-03 | 1999-11-03 | The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it |
AU12918/01A AU1291801A (en) | 1999-11-03 | 2000-11-02 | Salts of enalapril |
PCT/HU2000/000115 WO2001032689A1 (en) | 1999-11-03 | 2000-11-02 | Salts of enalapril |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9904011A HU226950B1 (en) | 1999-11-03 | 1999-11-03 | The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it |
Publications (4)
Publication Number | Publication Date |
---|---|
HU9904011D0 HU9904011D0 (en) | 2000-01-28 |
HUP9904011A2 true HUP9904011A2 (en) | 2001-10-28 |
HUP9904011A3 HUP9904011A3 (en) | 2003-01-28 |
HU226950B1 HU226950B1 (en) | 2010-03-29 |
Family
ID=89999904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9904011A HU226950B1 (en) | 1999-11-03 | 1999-11-03 | The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1291801A (en) |
HU (1) | HU226950B1 (en) |
WO (1) | WO2001032689A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0624082D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril metal salts |
ES2364011B1 (en) | 2009-11-20 | 2013-01-24 | Gp Pharm, S.A. | CAPSULES OF PHARMACEUTICAL ACTIVE AND ESTERS OF POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9111842A (en) * | 1991-11-25 | 1998-04-30 | Krka | Stable formulation of enalapryl salt, process for its preparation and its use |
ES2125198B1 (en) * | 1997-05-13 | 1999-11-16 | Vita Invest Sa | FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND AN ANTAGONIST OF THE CALCIUM CHANNELS, PROCEDURE FOR ITS PREPARATION AND USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. |
-
1999
- 1999-11-03 HU HU9904011A patent/HU226950B1/en unknown
-
2000
- 2000-11-02 WO PCT/HU2000/000115 patent/WO2001032689A1/en active Application Filing
- 2000-11-02 AU AU12918/01A patent/AU1291801A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU1291801A (en) | 2001-05-14 |
HUP9904011A3 (en) | 2003-01-28 |
HU9904011D0 (en) | 2000-01-28 |
WO2001032689A1 (en) | 2001-05-10 |
HU226950B1 (en) | 2010-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2478621A1 (en) | Botulinum toxin pharmaceutical compositions | |
HRP20030139B1 (en) | Peptidomimetic protease inhibitors | |
GB0108591D0 (en) | Therapeutic agents | |
NZ505453A (en) | Hypolipidemic benzothiazepine compounds | |
HUP0400456A2 (en) | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties and pharmaceutical compositions containing them | |
HUP0202570A1 (en) | Compositions and therapeutic methods involving isoflavones and analogues thereof | |
MXPA01006474A (en) | Colchinol derivatives as vascular damaging agents. | |
DE69533174D1 (en) | PYRIDOPYRIMIDINONE, CHINOLINE AND FELLED N-HETEROCYCLES AS BRADYKININE ANTAGONISTS | |
ATE468137T1 (en) | INHIBITORS OF HMGB1 FOR THE TREATMENT OF TISSUE DISEASES | |
TNSN06032A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
MXPA02007942A (en) | Pyrrolopyrimidinone derivatives, process of preparation and use. | |
TW200518753A (en) | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents | |
HUP0303923A2 (en) | Combinations of sterol absorbtion inhibitor(s) with cardiovascular agents for treatment cardiovascular conditions and pharmaceutical compositions containing the combination | |
HUP0400732A2 (en) | Pharmaceutically active uridine esters | |
BG106155A (en) | Novel derivatives and analogues of galanthamin | |
LV10717A (en) | Derivatives of triazolpyrimidine derived from these include pharmaceutical formulations and preparations for obtaining hundreds of compositions | |
SE0102440D0 (en) | New compound | |
AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
TR200101163T2 (en) | Bile water substituted phenyl-alkenoylguanidines, production methods, uses | |
HUP9802897A2 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
HUP9904011A2 (en) | Novel salts of dipeptid derivatives and use of them for producing pharmaceutical compositions | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
YU87501A (en) | Pharmaceutical complex | |
SE0004462D0 (en) | Novel method and use | |
HUP0402654A2 (en) | 2-[(2'-halo-3',5'-dialkoxyphenyl)-imino]-imidazolidine derivatives, use thereof and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC9A | Change of name, address |
Owner name: RICHTER GEDEON NYRT., HU Free format text: FORMER OWNER(S): RICHTER GEDEON VEGYESZETI GYAR RT., HU |